Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Phase 2 Obesity Trial New England Journal of Medicine (2023) The pivotal Phase 2 obesity trial of retatrutide, published in the New England Journal of Medicine, enrolled 338 adults with obesity (BMI 30) or overweight with weight-related comorbidities
March 5, 2025 AbbVie will pay Danish preclinical contract services and peptide drug discovery firm Gubra $350 million upfront
Melanotan (afamelanotide) was developed as a drug for the treatment of Protophorphyria erythropoetica and is used as a "designer drug" for body tanning
A.PerovaI
Declining NAD+ is closely associated with aging and metabolic slowdown
US$ 28.62
US$ 24.43
US$ 23.77
US$ 22.36
